SYMPLICITY HTN-3 (2014) — Trial Summary
SYMPLICITY HTN-3 (2014): Prospective, single-blind, randomized, sham-controlled trial of catheter-based renal artery denervation versus a sham procedure in adults with resistant hypertension on stable, maximally tolerated antihypertensive therapy (NCT01418261). Primary efficacy outcome: change in of
References
- Bhatt DL, Kandzari DE, O'Neill WW, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370(15):1393-1401.